CymitQuimica logo
Angiogenesis

Angiogenesis

Angiogenesis inhibitors are compounds that interfere with the formation of new blood vessels, a process critical in cancer growth and metastasis. By inhibiting angiogenesis, these compounds can restrict the blood supply to tumors, slowing or halting their growth. Angiogenesis inhibitors are essential in cancer research and therapeutic development, providing insights into the mechanisms of tumor progression and offering potential treatments for cancer and other angiogenesis-related diseases. At CymitQuimica, we offer a wide range of high-quality angiogenesis inhibitors to support your research in oncology and vascular biology.

Subcategories of "Angiogenesis"

Show 6 more subcategories

Found 2382 products of "Angiogenesis"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • Self-assembling peptide pY1


    Self-assembling peptide pY1, which aggregates around cancer cells, specifically targets the EGFR receptor. When co-cultured with Ovalbumin (OVA), pY1 effectively inhibits the endocytosis of OVA.
    Formula:C104H125N24O29P
    Color and Shape:Solid
    Molecular weight:2206.22

    Ref: TM-TP2934

    10mg
    To inquire
    50mg
    To inquire
  • EGFR-IN-15

    CAS:
    EGFR-IN-15 (compound I-005) is a potent EGFR inhibitor, exhibiting an IC50 value of 4 nM. This compound holds potential for oncological research applications.
    Formula:C24H25BrN6O2
    Color and Shape:Solid
    Molecular weight:509.408

    Ref: TM-T40209

    5mg
    873.00€
  • FLT3-IN-24


    FLT3-IN-24 (compound 24) is a potent and selective inhibitor of FLT3 kinase, with an IC50 of 7.94 nM. It also exhibits anti-proliferative effects on cells.
    Formula:C23H20N6O2S
    Molecular weight:444.13685

    Ref: TM-T208837

    10mg
    To inquire
    50mg
    To inquire
  • BCR-ABL-IN-3

    CAS:
    BCR-ABL-IN-3 irreversibly inhibits Bcr-Abl with <100 nM IC50, showing significant anti-cancer effects.
    Formula:C20H17ClF2N4O3S
    Color and Shape:Solid
    Molecular weight:466.89

    Ref: TM-T39732

    5mg
    873.00€
  • SC209

    CAS:
    SC209, a STRO-002 metabolite from patent WO2021247798, synthesizes anti-EGFR ADCs.
    Formula:C27H44N4O4
    Color and Shape:Solid
    Molecular weight:488.66

    Ref: TM-T74367

    5mg
    To inquire
    50mg
    To inquire
  • SJ1008030

    CAS:

    SJ1008030, a JAK2 PROTAC, degrades JAK2; EC50: 5.4 nM, IC50: 32.09 nM in MHH-CALL-4 cells for leukemia research.

    Formula:C42H43N13O7S
    Color and Shape:Solid
    Molecular weight:873.94

    Ref: TM-T74580

    5mg
    To inquire
    50mg
    To inquire
  • Arginyl-Glutamine

    CAS:
    Arginyl-Glutamine (Arg-Gln) is a dipeptide nutritional supplement that protects neonatal mice from hyperoxia-induced lung injury, lowering VEGF levels.
    Formula:C11H22N6O4
    Purity:95.2%
    Color and Shape:Solid
    Molecular weight:302.33

    Ref: TM-T76574

    1mg
    93.00€
    5mg
    178.00€
    10mg
    267.00€
    25mg
    454.00€
    50mg
    670.00€
    100mg
    1,004.00€
  • FLT3-IN-20


    FLT3-IN-20 (compound 34f) is a potent FLT3 inhibitor, demonstrating IC50 values of 1 nM for FLT3-D835Y and 4 nM for FLT3-ITD.
    Formula:C28H33N7O2S
    Color and Shape:Solid
    Molecular weight:531.67

    Ref: TM-T79596

    5mg
    To inquire
    50mg
    To inquire
  • AT-533

    CAS:
    AT-533 inhibits Hsp90, HSV, hinders HIF-1α/VEGF/VEGFR-2, Erk1/2, FAK, Akt/mTOR/p70S6K, and blocks tumor growth, angiogenesis, and HUVEC activities.
    Formula:C23H30N4O3
    Purity:99.67%
    Color and Shape:Soild
    Molecular weight:410.51

    Ref: TM-T67836

    1mg
    37.00€
    5mg
    82.00€
    10mg
    116.00€
    25mg
    207.00€
    50mg
    309.00€
    100mg
    447.00€
    200mg
    600.00€
    1mL*10mM (DMSO)
    86.00€
  • SOS1/EGFR-IN-2


    SOS1/EGFR-IN-2 (Compound 4) functions as a dual inhibitor of SOS1 and EGFR, exhibiting IC50 values of 8.3 and 14.6 nM, respectively. It demonstrates significant antiproliferative effects on cancer cells harboring various KRAS mutations.
    Formula:C25H29F3N4O3
    Color and Shape:Solid
    Molecular weight:490.52

    Ref: TM-T200843

    10mg
    To inquire
    50mg
    To inquire
  • FAK PROTAC B5

    CAS:
    FAK PROTAC B5: a degrader with 14.9 nM IC50, strong degradation, anti-growth, good plasma stability, and fair permeability.
    Formula:C41H43ClN10O7
    Color and Shape:Solid
    Molecular weight:823.3

    Ref: TM-T74281

    5mg
    To inquire
    50mg
    To inquire
  • VSLRGDTRG acetate


    VSLRGDTRG acetate is a synthetic peptide of the RGD motif from cadherin17 (CDH17), capable of binding to α2β1 integrin and activating its signaling pathways. It facilitates the high-affinity conformational change of β1 integrin via the RGD motif, enhancing cell adhesion and phosphorylation of FAK and ERK1/2, thereby promoting tumor proliferation and metastasis. VSLRGDTRG acetate is applicable in research on cancers expressing CDH17, such as colon and pancreatic cancers.
    Color and Shape:Odour Solid

    Ref: TM-TP3245

    10mg
    To inquire
    50mg
    To inquire
  • EGFR-IN-140


    EGFR-IN-140 (Compound 31) is an inhibitor of EGFR, effectively targeting both wild-type EGFR and the EGFRL858R/T790M/C797S mutant, with Ki values of 0.95 nM and 2.1 nM, respectively. Additionally, it inhibits EGFRdel19/T790M/C797S in Ba/F3 cells with an IC50 of 56.9 nM and demonstrates antitumor activity in mouse models.
    Formula:C27H37FN8O2
    Color and Shape:Solid
    Molecular weight:524.633

    Ref: TM-T204256

    10mg
    To inquire
    50mg
    To inquire
  • HER2-IN-14

    CAS:
    HER2-IN-14 (Compound 34) is a potent inhibitor of HER2, achieving an inhibitory concentration (IC50) of 18 nM.
    Formula:C26H23ClF2N8O3
    Color and Shape:Solid
    Molecular weight:568.96

    Ref: TM-T75165

    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • JAK-IN-15

    CAS:
    JAK-IN-15 is a JAK inhibitor. WO2016119700A1 (Compound 15).
    Formula:C22H23FN4O3S
    Color and Shape:Solid
    Molecular weight:442.51

    Ref: TM-T39400

    5mg
    873.00€
  • GSK143

    CAS:
    GSK143: Oral SYK inhibitor, pIC50=7.5, curbs pErk, anti-inflammatory, hinders immune cells in mice.
    Formula:C17H22N6O2
    Color and Shape:Solid
    Molecular weight:342.403

    Ref: TM-T38626

    5mg
    873.00€
  • PROTAC BTK Degrader-1

    CAS:
    Potent, selective oral PROTAC BTK Degrader-1; IC50: 34.51 nM (WT), 64.56 nM (BTK-481S); reduces BTK protein, inhibits tumors.
    Formula:C43H43N9O4
    Color and Shape:Solid
    Molecular weight:749.86

    Ref: TM-T74636

    5mg
    To inquire
    50mg
    To inquire
  • QL-X-138 HCl


    QL-X-138 HCl is a BTK/MNK dual kinase inhibitor with anticancer activity and anti-dengue virus 2 activity that inhibits BTK, MNK1, and MNK2 kinases.
    Formula:C25H20ClN5O2
    Purity:99.25%
    Color and Shape:Soild
    Molecular weight:457.91

    Ref: TM-T38960L

    1mg
    175.00€
    5mg
    434.00€
    10mg
    622.00€
    25mg
    973.00€
    50mg
    1,341.00€
  • PD-149163 hydrochloride


    PD-149163 hydrochloride is a neurokinin B agonist with antipsychotic activity, used for research on neurological diseases.
    Formula:C42H72ClN9O6
    Color and Shape:Solid
    Molecular weight:834.53

    Ref: TM-T70271L

    1mg
    175.00€
  • GNQWFI

    CAS:
    GNQWFI, an anti-Flt1 peptide, functions as a VEGFR1-specific antagonist. It inhibits interactions between VEGFR1 and various ligands, such as VEGFA, VEGFB, and placental growth factor (PIGF), and suppresses VEGF-induced endothelial cell migration and tubulogenesis. GNQWFI holds potential for research in cancer, asthma, and other ocular diseases.
    Formula:C37H49N9O9
    Color and Shape:Solid
    Molecular weight:763.84

    Ref: TM-TP2994

    10mg
    To inquire
    50mg
    To inquire